Trends in Nationally Notifiable Sexually Transmitted Disease Case Reports During the US COVID-19 Pandemic, January to December 2020.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
pubmed:
6
7
2021
medline:
23
9
2021
entrez:
5
7
2021
Statut:
ppublish
Résumé
To describe changes in reported sexually transmitted diseases (STDs) during the US coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019. We reviewed cases of chlamydia, gonorrhea, and primary and secondary (P&S) syphilis reported to the US National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to the number of 2019 cases reported in the same week, expressing 2020 cases as a percentage of 2019 cases. We also calculated the percent difference between 2020 and 2019 cumulative case totals as of MMWR week 50 (week of December 9). During MMWR weeks 1 to 11 (week of December 29, 2019-March 11, 2020), the weekly number of cases of STDs reported in 2020 as a percentage of the cases in the same week in 2019 was similar. However, 2020 numbers were much lower than 2019 numbers in week 15 (week of April 8; chlamydia, 49.8%; gonorrhea, 71.2%; and P&S syphilis, 63.7%). As of week 50, the 2020 cumulative totals compared with 2019 were 14.0% lower for chlamydia, 7.1% higher for gonorrhea, and 0.9% lower for P&S syphilis. During March-April 2020, national case reporting for STDs dramatically decreased compared with 2019. However, resurgence in reported gonorrhea and syphilis cases later in the year suggests STD reporting may have increased in 2020, underscoring the importance of continued STD prevention and care activities.
Sections du résumé
BACKGROUND
To describe changes in reported sexually transmitted diseases (STDs) during the US coronavirus disease 2019 pandemic, we compared the weekly number of reported nationally notifiable STDs in 2020 to 2019.
METHODS
We reviewed cases of chlamydia, gonorrhea, and primary and secondary (P&S) syphilis reported to the US National Notifiable Disease Surveillance System in 2020. For each STD, we compare the number of 2020 cases reported for a given Morbidity and Mortality Weekly Report (MMWR) week to the number of 2019 cases reported in the same week, expressing 2020 cases as a percentage of 2019 cases. We also calculated the percent difference between 2020 and 2019 cumulative case totals as of MMWR week 50 (week of December 9).
RESULTS
During MMWR weeks 1 to 11 (week of December 29, 2019-March 11, 2020), the weekly number of cases of STDs reported in 2020 as a percentage of the cases in the same week in 2019 was similar. However, 2020 numbers were much lower than 2019 numbers in week 15 (week of April 8; chlamydia, 49.8%; gonorrhea, 71.2%; and P&S syphilis, 63.7%). As of week 50, the 2020 cumulative totals compared with 2019 were 14.0% lower for chlamydia, 7.1% higher for gonorrhea, and 0.9% lower for P&S syphilis.
CONCLUSIONS
During March-April 2020, national case reporting for STDs dramatically decreased compared with 2019. However, resurgence in reported gonorrhea and syphilis cases later in the year suggests STD reporting may have increased in 2020, underscoring the importance of continued STD prevention and care activities.
Identifiants
pubmed: 34224523
doi: 10.1097/OLQ.0000000000001506
pii: 00007435-202110000-00015
pmc: PMC8459909
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
798-804Informations de copyright
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest and Sources of Funding: None declared.
Références
Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382:929–936.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. 2019. Available at: https://www.cdc.gov/std/stats18/default.htm . Accessed January 3, 2021.
Moreland A, Herlihy C, Tynan MA, et al. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement—United States, March 1–May 31, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1198–1203.
Czeisler M, Tynan MA, Howard ME, et al. Public attitudes, behaviors, and beliefs related to COVID-19, stay-at-home orders, nonessential business closures, and public health guidance—United States, New York City, and Los Angeles, May 5–12, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:751–758.
Centers for Disease Control and Prevention. Guidance for Businesses and Employers Responding to Coronavirus Disease 2019 (COVID-19). 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-business-response.html . Accessed January 3, 2021.
Centers for Disease Control and Prevention. COVID-19. 2020. Available at: https://ephtracking.cdc.gov/DataExplorer/ . Accessed January 3, 2021.
Executive Office of the President. Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak, Proclamation. Vol. 85, No. 53, March 18, 2020, 15337–15338. Available at: https://www.federalregister.gov/ . Accessed January 3, 2021.
Napoleon SC, Maynard MA, Almonte A, et al. Considerations for STI clinics during the COVID-19 pandemic. Sex Transm Dis 2020; 47:431–433.
Nagendra G, Carnevale C, Neu N, et al. The potential impact and availability of sexual health services during the COVID-19 pandemic. Sex Transm Dis 2020; 47:434–436.
Pampati S, Emrick K, Siegler AJ, et al. Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South. J Acquir Immune Defic Syndr 2021; 87:639–643.
Sanchez TH, Zlotorzynska M, Rai M, et al. Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020. AIDS Behav 2020; 24:2024–2032.
National Coalition of STD Directors. COVID-19 & the State of the STD Field. 2020. Available at: https://www.ncsddc.org/wp-content/uploads/2020/05/STD-Field.Survey-Report.Final_.5.13.20.pdf . Accessed January 3, 2021.
National Coalition of STD Directors. COVID-19 & the State of the STD Field: Phase II. 2020. Available at: https://www.ncsddc.org/wp-content/uploads/2020/08/STD-Field.Survey-Report.II_.Final-8.6.20.pdf . Accessed January 3, 2021.
National Coalition of STD Directors. COVID-19 & the State of the STD Field: Phase III. 2021. Available at: https://www.ncsddc.org/wp-content/uploads/2021/01/COVID19-State-of-STD-Field-Phase-III-Report-1.28.21-FINAL-1.pdf . Accessed January 3, 2021.
Centers for Disease Control and Prevention. MMWR Week. 2019. Available at: https://wwwn.cdc.gov/nndss/document/MMWR_Week_overview.pdf . Accessed January 3, 2021.
Centers for Disease Control and Prevention. Guidance on classifying STD case reports into MMWR week. 2018. Available at: https://www.cdc.gov/std/program/MMWR-week-guidance_2018January.pdf . Accessed January 3, 2021.
Stamm W. Chlamydia trachomatis infections in the adult. In: Holmes K, Sparling P, Stamm W, et al, eds. Sexually Transmitted Diseases. Vol 4th. New York, NY: McGraw-Hill, 2008:575–606.
Bachmann LH, Bolan G. Dear Colleague Letter: DSTDP Lab and Drug Shortages. 2020. Available at: https://www.cdc.gov/std/general/DCL-Diagnostic-Test-Shortage.pdf . Accessed January 3, 2021.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64(Rr-03):1–137.
Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. 2018. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf . Accessed January 3, 2021.
Berzkalns A, Thibault CS, Barbee LA, et al. Decreases in reported sexually transmitted infections during the time of COVID-19 in King County, WA: Decreased transmission or screening? Sex Transm Dis 2021; 48(8S):S44–S49.
Ogunbodede OT, Zablotska-Manos I, Lewis DA. Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections. Curr Opin Infect Dis 2021; 34:56–61.
Czeisler M, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19–related concerns—United States, June 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1250–1257.
Weinstock H, Grey J, Stenger M, et al. Impact of COVID-19 on STD Incidence [conference presentation]. 2020 STD Prevention Conference, Virtual. 2020. Available at: https://s6.goeshow.com/ncsd/prevention/2020/conference_schedule.cfm .
Centers for Disease Control and Prevention. Social Distancing. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html . Accessed January 3, 2021.
Turban JL, Keuroghlian AS, Mayer KH. Sexual health in the SARS-CoV-2 era. Ann Intern Med 2020; 173:387–389.
Cipriano M, Giacalone A, Ruberti E. Sexual behaviors during COVID-19: The potential risk of transmission. Arch Sex Behav 2020; 49:1431–1432.
Cope AB, Mobley VL, Samoff E, et al. The changing role of disease intervention specialists in modern public health programs. Public Health Rep 2019; 134:11–16.
Centers for Disease Control and Prevention. Public Health Activity Guidance. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-covid-19-client-interaction.html#appendix . Accessed January 3, 2021.
Centers for Disease Control and Prevention. COVID Data Tracker. 2021. Available at: https://covid.cdc.gov/covid-data-tracker/#cases_casesper100klast7days . Accessed June 3, 2021.